Earlier this summer the FDA asked Moderna for more efficacy data on its flu vaccine before it could review an mRNA-based ...

In a July 9 memo, the director of the FDA's Center for Biologics Evaluation and Research contended there was not enough ...

Find the latest Novavax, Inc. (NVAX) stock quote, history, news and other vital information to help you with your stock trading and investing.

The comments came in the context of questioning about a delay in the FDA's review of Novavax's latest version of its COVID-19 vaccine Nuvaxovid (NVX-CoV2705), which is intended to upgrade its ...